Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 30 Apr 2026 | 31 Jan 2026 | 31 Jul 2025 | 30 Apr 2025 | 31 Jan 2025 | 31 Jul 2024 |
|---|---|---|---|---|---|---|
| Revenue | 14.41B | 14.44B | 13.93B | 13.22B | 13.50B | 13.52B |
| Cost of revenue | 11.39B | 11.60B | 11.08B | 10.48B | 10.66B | 10.61B |
| Gross profit | 3.02B | 2.84B | 2.85B | 2.74B | 2.84B | 2.91B |
| Research and development | 432M | 392M | 406M | 401M | 397M | 413M |
| Selling, general and administrative | 1.51B | 1.50B | 1.45B | 1.48B | 1.46B | 1.40B |
| Operating expenses | 2.40B | 2.08B | 2.14B | 2.09B | 2.00B | 1.97B |
| Operating income | 612M | 759M | 716M | 654M | 845M | 940M |
| Pre-tax income | 493M | 671M | 624M | 506M | 704M | 827M |
| Income tax | 43M | 126M | −139M | 100M | 139M | 187M |
| Net income | 450M | 545M | 763M | 406M | 565M | 640M |
| Earnings per share | 0.49 | 0.59 | 0.81 | 0.43 | 0.60 | 0.65 |
| Earnings per share, diluted | 0.49 | 0.58 | 0.80 | 0.42 | 0.59 | 0.65 |
| Weighted average shares | 922M | 926M | 947M | 950M | 948M | 979M |
| Weighted average shares, diluted | 925M | 932M | 954M | 956M | 957M | 990M |
| Metric | 30 Apr 2026 | 31 Jan 2026 | 31 Oct 2025 | 31 Jul 2025 | 30 Apr 2025 | 31 Jan 2025 | 31 Oct 2024 | 31 Jul 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 3.70B | 3.15B | 3.71B | 2.87B | 2.73B | 2.89B | 3.25B | 2.88B |
| Receivables | 6.13B | 5.33B | 5.69B |
| Metric | 30 Apr 2026 | 31 Jan 2026 | 31 Jul 2025 | 30 Apr 2025 | 31 Jan 2025 | 31 Jul 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | — | 383M | — | — | 374M | — |
| Depreciation and amortisation | — | 214M | — |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 5.12B |
| 4.34B |
| 4.19B |
| 5.12B |
| 4.66B |
| Inventory | 9.20B | 8.74B | 8.51B | 8.36B | 8.18B | 8.44B | 7.72B | 7.79B |
| Current assets | 23.98B | 22.23B | 22.45B | 20.57B | 19.46B | 19.83B | 20.76B | 19.32B |
| Property, plant and equipment | 3.08B | 3.05B | 3.05B | 2.99B | 2.95B | 2.90B | 2.91B | 2.83B |
| Goodwill | 8.73B | 8.72B | 8.71B | 8.71B | 8.71B | 8.60B | 8.63B | 8.61B |
| Total assets | 42.94B | 41.54B | 41.77B | 39.85B | 38.80B | 38.93B | 39.91B | 38.06B |
| Current liabilities | 30.21B | 29.29B | 29.26B | 27.86B | 26.56B | 27.43B | 28.69B | 27.04B |
| Short-term debt | 810M | 861M | 845M | 820M | 1.45B | 1.42B | 1.41B | 1.40B |
| Long-term debt | 8.86B | 8.84B | 8.82B | 8.78B | 9.29B | 8.27B | 8.26B | 8.23B |
| Equity | −144M | −766M | −346M | −901M | −1.28B | −1.07B | −1.32B | −1.39B |
| Shares outstanding | 914M | 917M | 921M | 939M | 942M | 945M | 939M | 963M |
| Shares issued | 914M | 917M | 921M | 939M | 942M | 945M | 939M | 963M |
| 197M |
| — |
| Share-based compensation | — | 182M | — | — | 192M | — |
| Capital expenditure | — | 233M | — | — | 302M | — |
| Investing cash flow | — | −269M | — | — | −300M | — |
| Dividends paid | — | 277M | — | — | 273M | — |
| Share buybacks | 100M | 325M | 200M | 100M | 100M | 600M |
| Financing cash flow | — | −673M | — | — | −433M | — |